1. Home
  2. FRSX vs BRTX Comparison

FRSX vs BRTX Comparison

Compare FRSX & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRSX
  • BRTX
  • Stock Information
  • Founded
  • FRSX N/A
  • BRTX 1997
  • Country
  • FRSX Israel
  • BRTX United States
  • Employees
  • FRSX N/A
  • BRTX N/A
  • Industry
  • FRSX Computer Software: Prepackaged Software
  • BRTX Managed Health Care
  • Sector
  • FRSX Technology
  • BRTX Health Care
  • Exchange
  • FRSX Nasdaq
  • BRTX Nasdaq
  • Market Cap
  • FRSX 9.0M
  • BRTX 12.6M
  • IPO Year
  • FRSX 2017
  • BRTX N/A
  • Fundamental
  • Price
  • FRSX $0.50
  • BRTX $1.60
  • Analyst Decision
  • FRSX
  • BRTX Strong Buy
  • Analyst Count
  • FRSX 0
  • BRTX 1
  • Target Price
  • FRSX N/A
  • BRTX $18.00
  • AVG Volume (30 Days)
  • FRSX 480.7K
  • BRTX 151.8K
  • Earning Date
  • FRSX 08-08-2025
  • BRTX 08-12-2025
  • Dividend Yield
  • FRSX N/A
  • BRTX N/A
  • EPS Growth
  • FRSX N/A
  • BRTX N/A
  • EPS
  • FRSX N/A
  • BRTX N/A
  • Revenue
  • FRSX $436,000.00
  • BRTX $391,000.00
  • Revenue This Year
  • FRSX N/A
  • BRTX $391.52
  • Revenue Next Year
  • FRSX N/A
  • BRTX $3.50
  • P/E Ratio
  • FRSX N/A
  • BRTX N/A
  • Revenue Growth
  • FRSX N/A
  • BRTX 161.54
  • 52 Week Low
  • FRSX $0.45
  • BRTX $1.21
  • 52 Week High
  • FRSX $2.63
  • BRTX $2.55
  • Technical
  • Relative Strength Index (RSI)
  • FRSX 45.18
  • BRTX 45.93
  • Support Level
  • FRSX $0.45
  • BRTX $1.51
  • Resistance Level
  • FRSX $0.54
  • BRTX $1.79
  • Average True Range (ATR)
  • FRSX 0.05
  • BRTX 0.10
  • MACD
  • FRSX 0.01
  • BRTX -0.00
  • Stochastic Oscillator
  • FRSX 35.50
  • BRTX 32.14

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: